CClinicalTrials.gg
WithdrawnNCT04715451Updated Apr 24, 2025

Swaddling to Improve Neurodevelopment for Preterm Babies

An interventional study of Novel Swaddle in Preterm Birth and Neurodevelopmental Disorders, sponsored by Johns Hopkins University. Withdrawn. Open to participants aged 24 Weeks to 37 Weeks. Per ClinicalTrials.gov, last updated 2025-04-24.

Sponsored by Johns Hopkins University · Not applicable, Interventional, and Supportive care

Why this study was withdrawn
Study withdrawn due to staffing/funding concerns.
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
24 Weeks to 37 Weeks
Sex
All
01

Study summary

The investigators will test a new medical grade swaddling system for optimal and more appropriate positioning for preterm infants. This is a trial focused on sleep state, state regulation and long-term neurodevelopment. The central hypothesis is that this novel swaddling method will promote sleep and an optimal sleep-wake cycle, while also improving the neurodevelopment of preterm infants. It is proposed that adequate positioning and secondary feedback of natural movement of arms and legs stimulates and fosters normal brain development.

Read the detailed description

Throughout pregnancy, the fetus is encouraged to develop by maintaining proper flexed posture in the uterus and freely moving its arms and legs against the flexible boundaries of the womb. However, when born too early, preterm infants lose the natural boundaries of the womb that support this flexor positioning and movement support. In addition preterm infants undergo stress because of essential treatments in neonatal intensive care units and exposure to the extrauterine environment. To support the development of preterm infants, cotton wraps are often used to maintain appropriate body positioning. Swaddling helps maintain continuous and adequate body positioning which aids and provides a stable sleep environment and encourages muscle tone. However, traditional swaddling is challenging in preterm infants and preterm infants frequently become unswaddled. It is fraught with difficulties related to the neonatal care and monitoring preterm infants receive due to the prematurity. In addition, this stiff material does not provide the same sensory experience as the flexible boundaries of the womb. In response to this challenge, The Investigators developed a new medical grade swaddling system for optimal and more appropriate positioning and natural movement. Here, The Investigators outline a trial focused on sleep state, state regulation and long-term neurodevelopment. The central hypothesis is that this novel swaddling method will promote sleep and an optimal sleep-wake cycle, while also improving the neurodevelopment of preterm infants. It is proposed that adequate positioning and secondary feedback of natural movement of arms and legs stimulates and fosters normal brain development. The Investigators will clinically evaluate sleep at the level of amplitude-integrated electroencephalograph (aEEG) activity and perform the Prechtl's Assessment of General Movements (GMA) to assess spontaneous writhing and fidgety movements, which predicts the future neurodevelopment of preterm babies. The Investigators will also perform the Neonatal Intensive Care Unit (NICU) Network Neurobehavioural Scale (NNNS) as a standardized assessment of neurological integrity and organization. The goal is to provide early intervention to improve development in preterm infants.

02

Conditions studied

  • Preterm Birth
  • Neurodevelopmental Disorders

Keywords

  • Preterm
  • Brain
  • Neurodevelopment
  • Swaddling
03

In context

Premature Birth

2,554 studies on the registry are indexed under Premature Birth; 498 are open to participants now.

Browse Premature Birth studies →

Lead sponsor

Johns Hopkins University is the lead sponsor of 1,783 studies on the registry; 313 are open to participants now.

Of its 203 completed or terminated interventional studies of FDA-regulated products, 140 (69%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
24 Weeks to 37 Weeks
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Born very preterm (\<32 weeks postmenstrual age (PMA))
  • At least 12 hours and less than 2 months old
  • Expected to survive > 3 days
  • No congenital anomaly or genetic disorder with expected survival less than term equivalent
  • No malformations requiring surgery within 1 month of life
  • Central intravenous lines removed
  • Approval of the primary neonatologist, ideally not a study team member, to approach family for consent
  • Appropriate parent or guardian to provide informed consent

Exclusion criteria

Exclusion Criteria:

  • Life expectancy \< 3 days
  • Severe congenital anomaly or genetic disorder with life expectancy \<40 weeks PMA
  • Seizures
  • Need for seizure medication
  • Hypertension for age requiring medication
  • Severe hematologic crisis such as disseminated intravascular coagulation
  • Hydrops fetalis
  • Clinical concern or diagnosis of toxoplasmosis, cytomegalovirus rubella or syphilis infection
  • Clinical concern or diagnosis of severe acute respiratory distress syndrome coronavirus 2 (SARS CoV-2) or coronavirus disease (COVID-19)
  • Central intravenous access and reliance on parenteral nutrition >50%
  • Respiratory support greater than nasal canulae or nasal continuous positive airway pressure (CPAP) (i.e. ventilator dependent)
  • Active infection, including need for antibiotics greater than 5 days (i.e. confirmed infection)
  • Complex congenital heart disease
  • Known chromosomal abnormalities
  • Clinical or echocardiographic signs of symptomatic pulmonary hypertension
  • Profound perinatal hypoxia-ischemia
  • Receiving treatment for pain control
  • Sustained tachypnea >80 breaths/minute
  • Need for volume expansion or administration of inotropes
  • No one available or willing to provide consent
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
0 participants (actual)

Study arms

  • No intervention
    Conventional Swaddle

    The management of the non-intervention group is with a cotton swaddle that is standard of care. It represents a conventional standard management method using a swaddle made of cotton.

  • Experimental
    Novel Swaddle

    The Novel Swaddle is made of fabric consisting of 85% nylon and 15% polyurethane. This fabric provides heat retention, is hygroscopic and stretches in both longitudinal and transverse directions, thus more accurately replicating the intrauterine environment. The novel material is sewed into a bag shape.

    Other: Novel Swaddle

Interventions

  • OtherNovel Swaddle

    A novel swaddling method.

06

What researchers measure

Primary outcomes

  1. Change in Sleep-Wake Cycling Maturity as assessed by amplitude integrated EEG (aEEG) readings

    Using aEEG, the Investigators will assess the presence or absence of mature sleep-wake cycling as defined as regular rhythmic sinusoidal variations of amplitude with a cycle greater than or equal to 20 minutes. Tracings with a cycling pattern that does not fit into a mature sleep-wake cycle for the majority of the tracing will be classified as intermediate.

    Time frame: 32 weeks postmenstrual age, 34 weeks postmenstrual age and 36 weeks postmenstrual age

  2. Change in length of time spent in sleep

    Using aEEG, the Investigators will assess the change in length of time (in minutes) spent in sleep.

    Time frame: 32 weeks postmenstrual age, 34 weeks postmenstrual age and 36 weeks postmenstrual age

  3. Change in the number of awakenings in a 3 hour time period

    Using aEEG, the Investigators will assess the change in number of awakenings in a 3 hour time period.

    Time frame: 32 weeks postmenstrual age, 34 weeks postmenstrual age and 36 weeks postmenstrual age

  4. Change in voltage as assessed by aEEG) readings

    Using aEEG, the Investigators will assess the change in voltage (measured in microvolts).

    Time frame: 32 weeks postmenstrual age, 34 weeks postmenstrual age and 36 weeks postmenstrual age

  5. Change in ratio of active sleep and quiet sleep as assessed by amplitude integrated EEG (aEEG) readings

    Using aEEG The Investigators will assess the time spent in active sleep (irregular and low in amplitude) and quiet sleep (regular and high in amplitude).

    Time frame: 32 weeks postmenstrual age, 34 weeks postmenstrual age and 36 weeks postmenstrual age

  6. Change in Sleep-Wake Cycling Continuity as assessed by amplitude integrated EEG (aEEG) readings

    Using aEEG The Investigators will examine the background activity on recordings to assess the presence or absence of isoelectric periods along with amplitude fluctuations. Tracings will be classified as continuous, discontinuous and borderline.

    Time frame: 32 weeks postmenstrual age, 34 weeks postmenstrual age and 36 weeks postmenstrual age

Secondary outcomes

  1. Behavioral Maturity as assessed by the NNNS

    The NICU Network Neurobehavioural Scale (NNNS) is a standardized clinical assessment tool used to assess neurological integrity and organization in a single, structured clinical exam. Summary scores are created for neurobehavioral domains including: habituation, attention, handling, quality of movement, self-regulation, non optimal reflexes, asymmetrical reflexes, stress/abstinence, arousal, hypertonicity, excitability, and lethargy. 13 summary scores will be generated.

    Time frame: 37 weeks postmenstrual age

  2. Change in General Movements as assessed by the GMA

    Prechtl's General Movement Assessment (GMA) is a clinical assessment tool that classifies writhing movements in preterm infants. Specifically, classification of writhing movements will be made as cramped synchronous, poor repertoire with cramped synchronicity, or poor repertoire.

    Time frame: 32 weeks postmenstrual age and 37 weeks postmenstrual age

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Kitase Y, Sato Y, Takahashi H, Shimizu M, Ishikawa C, Yamamoto H, Hayakawa M. A new type of swaddling clothing improved development of preterm infants in neonatal intensive care units. Early Hum Dev. 2017 Sep;112:25-28. doi: 10.1016/j.earlhumdev.2017.06.005. Epub 2017 Jul 1. PubMed 28675824 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04715451
Lead sponsor
Johns Hopkins University
Collaborators
The Thomas Wilson Sanitarium for Children of Baltimore City
Responsible party
Sponsor
First posted
Jan 20, 2021
Start date
Apr 21, 2025
Primary completion
Apr 21, 2025
Completion
Apr 21, 2025
Last update
Apr 24, 2025

Study contacts

Lauren Jantzie, PhD
principal investigator · Johns Hopkins University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion